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Abstract
Background: In rat, deafferentation of one labyrinth (unilateral labyrinthectomy) results in a
characteristic syndrome of ocular and motor postural disorders (e.g., barrel rotation, circling
behavior, and spontaneous nystagmus). Behavioral recovery (e.g., diminished symptoms),
encompassing 1 week after unilateral labyrinthectomy, has been termed vestibular compensation.
Evidence suggesting that the histamine H3 receptor plays a key role in vestibular compensation
comes from studies indicating that betahistine, a histamine-like drug that acts as both a partial
histamine H1 receptor agonist and an H3 receptor antagonist, can accelerate the process of
vestibular compensation.
Results: Expression levels for histamine H3 receptor (total) as well as three isoforms which display
variable lengths of the third intracellular loop of the receptor were analyzed using in situ
hybridization on brain sections containing the rat medial vestibular nucleus after unilateral
labyrinthectomy. We compared these expression levels to H3 receptor binding densities.
Total H3 receptor mRNA levels (detected by oligo probe H3X) as well as mRNA levels of the three
receptor isoforms studied (detected by oligo probes H3A, H3B, and H3C) showed a pattern of
increase, which was bilaterally significant at 24 h post-lesion for both H3X and H3C, followed by
significant bilateral decreases in medial vestibular nuclei occurring 48 h (H3X and H3B) and 1 week
post-lesion (H3A, H3B, and H3C). Expression levels of H3B was an exception to the forementioned
pattern with significant decreases already detected at 24 h post-lesion. Coinciding with the
decreasing trends in H3 receptor mRNA levels was an observed increase in H3 receptor binding
densities occurring in the ipsilateral medial vestibular nuclei 48 h post-lesion.
Conclusion: Progressive recovery of the resting discharge of the deafferentated medial vestibular
nuclei neurons results in functional restoration of the static postural and occulomotor deficits,
usually occurring within a time frame of 48 hours in rats. Our data suggests that the H3 receptor
may be an essential part of pre-synaptic mechanisms required for reestablishing resting activities 48
h after unilateral labyrinthectomy.
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In rat, deafferentation of one labyrinth (unilateral laby-
rinthectomy) results in a characteristic syndrome of ocular
motor and postural disorders. These disorders have been
divided into two categories : One category of symptoms,
called static, includes head rotation in both the frontal
and horizontal planes and ocular nystagmus [1]. The
other category, called dynamic, corresponds to a
decreased gain of the vestibulo-ocular and vestibulo-spi-
nal refelxes [1]. Behavioral recovery (e.g., diminished
symptoms), encompassing 1 week after unilateral laby-
rinthectomy, has been termed vestibular compensation
[2]. Moreover, the time course of recovery is very different
for static and dynamic reflexes: static deficits disappear in
one week but dynamic deficits tend to take several months
to normalize. Because unilateral labyrinthectomy results
in a permanent loss of vestibular inputs from the lesioned
side, the compensatory process is assumed to be attribut-
able to the reorganization of the neural network in the
central vestibular system [3,4]. Many brain regions includ-
ing, the medial vestibular nucleus (MVe), are implicated
in this process of recovery [5-7].
The focus of our study is the histamine H3 receptor that
was initially characterized as an autoreceptor controlling
histamine synthesis and release [8,9]. Subsequently, as a
heteroreceptor, the H3 receptor was found to mediate pre-
synaptic inhibition of release of histamine, noradrena-
line, serotonin, dopamine, glutamate, GABA and
tachykinins [10-13], presumably by inhibiting calcium
channels [14-16]. The histamine H3 receptor was recently
cloned from human [17], monkey [18], rat [19], mouse
[20], and guinea pig [21]. Moreover, the receptor was
found to have several isoforms [21-26] with differential
coupling to second messenger systems and a variation in
their distribution in a region-specific manner. The iso-
forms are formed by alternative splicing of the messenger
RNA (mRNA; [22,24]). This study involves analysis of
trends observed in mRNA expression levels for the H3
receptor (H3X, the oligonucleotide probe detecting all H3
receptor mRNAs characterized so far) as well as three of
the known functionally active isoforms (H3A, H3B, and
H3C), described by Drutel et al. [24], during the process of
post-lesional plasticity in the central nervous system
(CNS).
The primary source of histamine (e.g., ligand for H3 recep-
tors) are histaminergic perikarya located exclusively in the
tuberomammillary nuclei of the posterior hypothalamus
[27,28]; these same neurons send axonal projections to
many areas of the brain including the vestibular nuclear
complex in rat [29-32]. The fact that the rat vestibular
nuclear complex is endowed with the H3 receptor was
established by use of ligand binding [33,34] and in situ
hybridization methods [34].
Evidence suggesting that the H3 receptor plays a key role
in vestibular compensation comes from studies indicating
that betahistine, a histamine-like drug that acts as both a
partial histamine H1 receptor agonist and an H3 receptor
antagonist [14,35], accelerates the process of vestibular
compensation [32,36]. Furthermore, studies have shown
that betahistine treatment results in a reduction of [3H]N-
α-methylhistamine labelling in the vestibular nuclear
complex [37]; these findings suggest that betahistine
increases histamine turnover and release by blocking pre-
synaptic H3 receptors and inducing H3 receptor downreg-
ulation [37]. It is noteworthy that dynamic vestibular
functions can be modulated by H3 receptor ligands, e.g.,
thioperamide [38]; moreover, thioperamide can affect
tonic vestibular functions as well with its demonstrated
ability to attenuate barrel rotation in rats following unilat-
eral labyrinthectomy [39]. The forementioned studies
make tenable the view that further elucidation of H3
receptor regulation is required to fully understand the
process of vestibular compensation.
The detailed aim of this study was to characterize the pat-
terning of mRNA expression levels for all possible mRNA
splice variants of the H3 receptor (H3X; as described in
[24]) and its isoforms which display different variations
of the third intracellular loop (H3A, H3B, and H3C; as
described in [24]) in the medial vestibular nucleus (MVe)
during the process of vestibular compensation.
Moreover, in this study, we compared the aforementioned
trend in mRNA expression levels with H3 receptor binding
densities to reveal the possible plastic changes in the H3
receptor which is responsible for significant constitutive
activity also in vivo [40], histamine-mediated regulation of
neurotransmitter release, and therapeutic effects of
betahistine.
Results
Expression patterns of total H3 receptor and H3 receptor 
isoforms (H3A, H3B, and H3C)
Changes in mRNA expression levels for H3 receptor and
the three H3 receptor isoforms (Figure 1A,1B,1C and 1D,
respectively) occured bilaterally; that is, there were no sig-
nificant differences detected between the ipsilateral and
contralateral medial vestibular nuclei of animals in all
groups studied (e.g., control, 4 h post-lesion, 24 h post-
lesion, 48 h post-lesion [n = 4, for each group], and 1
week post-lesion [n = 5]).
We compared the total H3 receptor mRNA expression lev-
els (using probe H3X) in ipsilateral MVe of control animals
to that of test animals from the four time points (Fig. 1A).
Fig. 2B shows scanned X-ray film depiction of H3X expres-
sion in a representative animal 24 h post-lesion. We
found no significant rise in H3X mRNA levels in thePage 2 of 9
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increases in H3X mRNA levels were found to occur at 24
and 48 hours post-lesion. After 1 week post-lesion, H3
receptor mRNA expression levels (as indicated by probe
H3X) returned to normal levels. The trend observed was
similar when comparing H3X mRNA levels in contralateral
MVe of control animals with that of test animals from the
four time points. There was no significant change in total
H3 receptor mRNA levels detected in contralateral MVe 4
hours post-lesion, but we found a significant increase in
H3X mRNA levels detected in contralateral MVe both 24
hours and 48 hours post-lesion. Finally, a return to nor-
mal levels in total H3X receptor mRNA level was detected
in contralateral MVe 1 week post-lesion.
No significant increases in H3A mRNA expression levels
were detected when we compared ipsilateral MVe in con-
trol animals with ipsilateral MVe 4 hours, 24 hours, and
48 hours post-lesion (Fig. 1B). Fig. 2D shows scanned X-
ray film depiction of H3A expression in a representative
animal 24 h post-lesion. On the other hand, a significant
decrease of H3A mRNA levels does occur in the ipsilateral
MVe 1 week after lesioning. The trend was identical when
comparing H3A mRNA levels in contralateral MVe of con-
trol animals with H3A mRNA levels in contralateral MVe of
animals from the four time points: There was no signifi-
cant increase in H3A mRNA levels when comparing to con-
tralateral MVe 4 hours, 24 hours, and 48 hours post-
lesion; on the other hand, there is a significant decrease in
H3A mRNA levels when comparing to contralateral MVe 1
week after lesioning.
No significant changes in H3B mRNA expression levels
were detected when we compared ipsilateral MVe in con-
trol animals to ipsilateral MVe 4 hours post-lesion (Fig.
1C). Fig. 2F shows scanned X-ray film depiction of H3B
expression in a representative animal 24 h post-lesion.
Significant decreases in mRNA levels were found in the
ipsilateral MVe 24 hours, 48 hours, and 1 week after
lesioning. When comparing contralateral MVe of control
animals to contralateral MVe of animals in the other time
points, there was a significant increase detected 4 hours
A, B, C, and D – Expression levels of the total histamine H3 receptor (using probe H3X) and its three isoforms (H3A, H3B, and H3C) at 4 h, 24 h, 48 h, and 1 w ek post-lesionFigure 1
A, B, C, and D – Expression levels of the total histamine H3 receptor (using probe H3X) and its three isoforms 
(H3A, H3B, and H3C) at 4 h, 24 h, 48 h, and 1 week post-lesion. Data are presented as mean IOD ± SEM. Abbreviations 
are as follows: ipsi, ipsilateral; contra, contralateral; cntrl, control (n = 4); 4 h, animals sacrificed 4 h post-lesion (n = 4); 48 h, 
animals sacrificed 48 h post-lesion (n = 4); and 1 wk, animals sacrificed 1 week post-lesion (n = 5). ***p < 0.001 and **p < 0.01 
when compared to ipsilateral control. ###p < 0.001, ##p < 0.01, and #p < 0.05 when compared to contralateral control.Page 3 of 9
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detected at 24 hours, 48 hours after lesion, and 1 week
post-lesion.
No significant changes in H3C mRNA levels were detected
when we compared ipsilateral MVe in control animals to
ipsilateral MVe 4 hours post-lesion (Fig. 1D). Fig. 2H
shows scanned X-ray film depiction of H3C expression in a
representative animal 24 h post-lesion. A significant
increase was detected when comparing ipsilateral MVe of
control animals to ipsilateral MVe 24 hours post-lesion;
moreover, the decrease in H3C mRNA levels in the ipsilat-
eral MVe 48 hours post-lesion was not significantly differ-
ent from those of the ipsilateral MVe in control animals.
Finally, in comparison to the ipsilateral MVe in controls,
there was a decrease in mRNA levels that was found to be
significant in the ipsilateral MVe 1 week post-lesion.
Results were similar when comparing the contralateral
MVe in control animals to contralateral MVe from the
other time points: There was no significant increase in H3C
mRNA levels when comparing to contralateral MVe 4
hours post-lesion, there was a significant increase detected
when comparing to contralateral MVe 24 hours post-
lesion, the decrease was not significant comparing to con-
tralateral MVe 48 hours post-lesion, and a significant
decrease was detected when comparing to contralateral
MVe 1 week post-lesion.
[125I]iodoproxyfan Binding Densities
No significant changes were found in H3 receptor binding
densities (Fig. 3) between ipsilateral MVe in control ani-
mals (n = 3) and ipsilateral MVe of animals of different
time points. The results were identical when H3 receptor
binding densities in contralateral MVe in control animals
were compared to that of contralateral MVe at different
times post-lesion. On the other hand, when comparing
the ipsilateral to contralateral MVe 48 hours post-lesion, a
significant increase in binding densities occurred on the
ipsilateral side (Fig. 4 shows an example of H3 receptor
binding densities in a representative animal 48 h post-
lesion).
Discussion
Knowing that there is no reliable method to determine the
efficiency of a probe for its targetted sequence in an mRNA
of interest, this study focuses instead on the pattern of
expression for the total H3 receptor (detected by using
probe H3X) and its isoforms (H3A, H3B, and H3C) occurring
during the process of post-lesional plasticity in the CNS.
Moreover, the probes used in this study were designed to
detect unique areas in the transcripts (H3A), or junctional
areas in deletion isoforms (probes H3B and H3C) which
would make it highly unlikely for non-specific hybridiza-
tion would occur. This study also includes a comparison
A) Location of the MVe as visualized on cresyl violet stained secti n and on x-ray images of parallel se tions used in in situ hybridiz tion exp riments with th  various ligonucleot d  probes: B) H3X C) H3X block ng contr l D) H3A E) H3A block-ing c tr l F) H3B G) H3B blocking control ) H3C I) H3C bl cki g c trolFi ure 2
A) Location of the MVe as visualized on cresyl violet 
stained section and on x-ray images of parallel sec-
tions used in in situ hybridization experiments with 
the various oligonucleotide probes: B) H3X C) H3X 
blocking control D) H3A E) H3A blocking control F) 
H3B G) H3B blocking control H) H3C I) H3C blocking 
control. Sections are from a representative animal sacrificed 
24 h post-lesion. Abbreviations are as follows: MVe, medial 
vestibular nucleus and Pr, prepositus nucleus. Scale bars are 
100 µm.Page 4 of 9
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ing densities for the H3 receptor.
The prepositus nuclei are delineated and mentioned in
legends for figures 2 and 4. These nuclei are delineated for
the sole purpose of giving the reader an idea of the dors-
oventral extent of the MVe at the levels depicted in figures
2 and 4. Noteworthy, is that these nuclei are not included
in the main functional projections in the vestibulo-ocular
and vestibulo-spinal pathways from the brainstem vestib-
ular nucleus in mammals reviewed by Smith and
Curthoys [2].
There are three previously described types of neurons in
the medial vestibular nucleus [41,42]; in vitro, all three
types are depolarized by histamine [43,44]. Moreover,
this depolarization has been shown to be exclusively
mediated through postsynaptic H2 receptors [43,44] sug-
gesting a presynaptic localization of H3 receptors in the
medial vestibular nuclei [38]. Consequently, there are
three possible locations for H3 receptors in the MVe: 1)
On the histaminergic or other incoming fibers innervating
the MVe [29-32]. 2) On terminals of the inhibitory
interneurons in the MVe that make synaptic contacts on
second order excitatory neurons-defined as neurons in the
vestibular nuclei that receive inputs from sensory afferents
[45]. 3) On the terminals of second order excitatory MVe
neurons making cross-commissural synaptic contacts on
contralateral MVe inhibitory interneurons [45]. With
respect to MVe on the lesioned side, an H3 receptor medi-
ated inhibition of GABA release from inhibitory interneu-
rons or glutamate release from terminals of second order
excitatory MVe neurons may underlie the restoration of
resting activity in the deafferentated MVe; more precisely,
H3 receptor action would result in disinhibition of neu-
rons in the deafferentated MVe
With respect to the first possible location, it has been
established that histamine fibers are endowed with H3
receptors that function as autoreceptors and inhibit hista-
mine release [11,13]. Support for the notion that H3
receptors are at the next two possible locations (i.e., either
at the terminals of the inhibitory interneurons or at the
[125I]iodoproxyfan binding densities in MVe of labyrinthect-omized ratsFigure 3
[125I]iodoproxyfan binding densities in MVe of laby-
rinthectomized rats. Data are presented as mean IOD ± 
SEM. Abbreviations are as stated in Figure 1 legend. Sample 
sizes are as follows: control, n = 3; 4 h post-lesion, n = 4; 24 
h post-lesion, n = 4; 48 h post-lesion, n = 4; 1 week post-
lesion, n = 5. *p = 0.0193.
A) Location of the MVe as visualized at high magnification and B  at magnification used in analyses on cresyl violet s ai ed secti n and C) on x-ray m ges of parallel ecti ns used in [125I]iodoproxyfa binding experimen s; D) non-specific bi -ing c tr l is represented in thi  im geFi ure 4
A) Location of the MVe as visualized at high magnifi-
cation and B) at magnification used in analyses on 
cresyl violet stained section and C) on x-ray images 
of parallel sections used in [125I]iodoproxyfan binding 
experiments; D) non-specific binding control is rep-
resented in this image. Sections are from a representative 
animal sacrificed 48 h post-lesion. Abbreviations are as stated 
in Figure 2 legend. Scale bars are 100 µm.Page 5 of 9
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work showing that betahistine antagonizes the excitatory
effect of histamine on vestibular neurons from in vitro
slice preparations of the dorsal brainstem of the rat [46].
This finding is significant given that H3 receptors mediate
presynaptic inhibition of release of other neurotransmit-
ters including: noradrenaline, serotonin, dopamine,
glutamate, GABA and tachykinins [10-13]. Unilateral lab-
yrinthectomy induced changes in expression levels of
receptors for glutamate (e.g., NR1 and NR2A-D subunits
of the NMDA receptor [47] and GluR2-4 subunits of the
AMPA receptor [48]) have been studied in the vestibular
nuclei. Moreover, the existence of both GABAA and GABAB
receptors in the vestibular nuclei and their involvement in
vestibular compensation has been demonstrated by either
unilateral perfusion or microinjection of GABAergic ago-
nists and antagonists (e.g., GABA, muscimol, and bicucul-
line) [49].
Consequently, an H3 receptor antagonist such as betahis-
tine could either facilitate GABA release from inhibitory
interneurons located in the MVe that make synaptic con-
tacts with second order neurons or facilitate glutamate
release from terminals of second order MVe neurons that
synapse on inhibitory interneurons in the contralateral
MVe [31,45]. Either scenario would lead to an inhibition
of second order neurons in the MVe and this would
explain the observation that betahistine antagonizes the
excitatory effect of histamine on vestibular neurons [46].
On the other hand, betahistine administration is reported
to induce recovery with a time benefit of 2 weeks relative
to control animals after unilateral vestibular neurectomy
[32,36]; this is thought to be due to a bilateral increase in
histamine release in the MVe [32,37]. The increased hista-
mine would be bound by H2 receptors on the perikarya of
MVe neurons ipsilateral and contralateral to the lesion
resulting in a bilateral increase in activity. This should
facilitate behavioral recovery as it is thought that an
imbalance in discharge of MVe neurons (30–40 spikes/s
in normal animals [4]) ipsilateral and contralateral to the
lesion underlies the static postural and occulomotor
deficits triggered by unilateral labyrinthectomy [45]. Yet,
as stated before, the actions of betahistine would also
extend to H3 receptors located on glutamatergic terminals
of contralateral MVe neurons or on GABAergic terminals
of inhibitory MVe interneurons. Antagonism of H3 recep-
tors at either site may also act to speed recovery by increas-
ing the amount of GABA output from terminals of
inhibitory interneurons and, as a consequence, equalizing
neuronal discharge activity of ipsilateral and contralateral
MVe.
The trends toward bilateral increases (24 h post-lesion)
followed by decreases (48 h post-lesion) in total H3 recep-
tor and H3A, and H3C isoform mRNA levels, with H3B
mRNA levels already increasing at 4 hours post-lesion and
decreasing at 24 h post-lesion, coinciding with a signifi-
cant increase in H3 receptor binding densities in the ipsi-
lateral MVe detected 48 hours post-lesion suggests the
occurrence of one or a combination of events in the ipsi-
lateral MVe: 1) an increase in translation has occurred. 2)
A change in receptor trafficking between intracellular
stores and cell membrane has occurred so that it can be
detected as an increase in H3 receptor receptor binding
densities. In either case, an increase in functional H3
receptor protein coupled with an increase in receptor
activity may lead to a restoration of resting activity in the
deafferentated MVe by scenarios already mentioned in
this section.
Conclusions
Our findings are significant given that normalization of
resting activities in neurons located in the ipsilateral MVe
has been shown to occur 48 hours after unilateral laby-
rinthectomy [50]. Moreover, by 48 hours post-lesion,
commissural disinhibition has been observed to occur
[51]. Placement of H3 receptors at the terminals of either
GABAergic inhibitory MVe interneurons or on terminals
of glutamatergic second order MVe neurons with contral-
ateral projections should result in the observed commis-
sural disinhibition as increased H3 receptor activity would
result in an inhibition of synaptic release of
neurotransmitters.
Our data would thus suggest that H3 receptors are
involved in presynaptic mechanisms resulting in a nor-
malization of resting activities in ipsilateral MVe neurons




This study was approved by the Local Committee for Ani-
mal Experiments and the Provincial State Office of West-
ern Finland; in addition, animal experiments were in
accordance with the European Convention (1986) guide-
lines and approved by the Animal Ethics Committee of
Abo Akademi Unviversity. Adult male Sprague Dawley
rats (200–250 g) were used. Intraperitoneal (ip) injection
of pentobarbital (45 mg/kg ip; Mebunat, Orion, Finland)
was used as an anesthetic; in addition, local anesthetic
Lidocain (Orion, Finland) was infiltrated under the skin
and periosteum prior the procedure. Three steps initiated
the surgical procedure to left side of the animal's head: ret-
roauricular skin incision, opening of the middle ear bulla
with a drill, and removal of the ossicular chain with the
aid of a microscope. Unilateral labyrinthectomy was car-
ried out by opening the horizontal semicircular canal duct
in the temporal bone, drilling through the horizontal andPage 6 of 9
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contents of the vestibule. 100% ethanol was injected into
the opened labyrinth to finalize the procedure; finally, the
wound was sutured. The sham operation entailed opening
the middle ear bulla and leaving the ossicular chain intact
prior to suturing the wound, as described in Cameron and
Dutia [52]; the control animals (n = 4) that underwent the
sham operation were killed 4 h later. The method is
explained hereafter. All rats included in the experiments
displayed symptoms characteristic of animals that have
undergone unilateral labyrinthectomy (e.g., barrel rota-
tion, circling behavior, and spontaneuos nystagmus).
These symptoms gadually disappeared during the first two
or three days and were completely absent within one
week. Animals were stunned by CO2 gas and killed by
decapitation 4 h (n = 4), 24 h (n = 4), 48 h (n = 4) and 1
week (n = 5) after labyrinthectomy.
Tissue preparation
After the mentioned decapitation, brains were removed,
frozen in isopentane (-25°C), and stored at -70°C. Tis-
sues were then cut to 20 µm thick cryosections, thaw
mounted onto poly-L-lysine coated slides (Menzel-Gläser,
Germany), and stored at -70°C until used.
In-situ hybridization histochemistry
The oligonucleotide probes used for in situ hybridization
were designed so that they specifically recognized the dif-
ferent H3 receptor isoform mRNAs (H3A, H3B, and H3C; as
described in [24]); an additional oligonucleotide probes
was used to detect all characterized H3 receptor isoforms
(H3X; as described in [24]). Sequences for H3X, H3A, H3B,
and H3C probes have been previously published [24]. It is
noteworthy that the isoform-specific probes detect selec-
tively the various deletion forms of the third intracellular
loop, but do not differentiate between the possible alter-
native C-termini of the H3 receptor isoforms [53]. How-
ever, it has been shown that the differences in the third
intracellular loop are significant for coupling to intracellu-
lar second messengers [24]. As a control, we used a nor-
mal hybridization mixture with a 100-fold excess of
unlabeled specific probes. As an additional control, we
used a Staphylococcus aureus chloramphenicol acetyltrans-
ferase-specific oligonucleotide probe. The hybridization
procedure used has been described before and was used
with minor modifications [54,55]. All probes were
labeled with [35S]deoxyadenosine 5'-α(-thio) triphos-
phate (New England Nuclear, USA) at their 3' ends using
terminal deoxynucleotide transferase (Promega, USA).
Nonincorporated nucleotides were removed by purifica-
tion through Sephadex G-50 columns.
Before hybridization, cryosections were taken from the -
70°C environment and kept at room temeprature for 10
min and treated with UV light for 5 min. The hybridiza-
tion (107cpm/ml) was carried out at 50°C for 16 to 20
hours in a humidified chamber. Posthybridization washes
were carried out as described previously [55]. Brain sec-
tions from control animals and animals 4 h, 24 h, 48 h,
and 1 week post-lesion were treated simultaneously with
their respective oligonucleotide probe. Sections and car-
bon-14 standards were exposed to Kodak BioMax X-ray
films (Kodak, USA) for 10 days.
Receptor binding autoradiography
Autoradiographic localization of [125I]iodoproxyfan bind-
ing sites has been described before [56]. Briefly, slide
mounted tissue sections were preincubated for 15 min in
50 mM Na2HPO4-KH2PO4 phosphate buffer, pH 6.8, con-
taining 0.1% bovine serum albumin and 1 µM S132 (a 1-
substituted imidazole derivative displaying a very low
affinity at H3 receptors and used to decrease non-specific
labelling). The sections were then incubated for 1 hour at
room temperature in the same buffer containing 15 pM
[125I]iodoproxyfan (Amersham Pharmacia Biotech UK
Limited, England). Non-specific binding was determined
by incubating consecutive sections in the presence of 1
µM (R)α-methylhistamine (Sigma-Aldrich, Germany). At
the completion of incubation, the tissues were washed
four times (4 min each) in the same fresh ice-cold buffer,
dipped into ice-cold water, and dried under a current of
air. Brain sections from control animals and animals 4 h,
24 h, 48 h, and 1 week post-lesion were treated simulta-
neously. Dried sections, along with standards, were
exposed to Kodak BioMax X-ray films (Kodak, USA) for 2
days.
Image analysis and statistics
Autoradiographic films were quantified by digitizing the
film images with a computer based MCID 5+ image anal-
ysis system (Imaging Research, Canada) and by measur-
ing gray scale pixel values. The relative optic density was
converted to integrated optic density (IOD) based on a
standard curve derived from standards exposed to films.
Gray scale values were determined from four sections for
each animal, measurements from white matter of each
respective section were subtracted to obtain the final val-
ues, and the data were analyzed using either a paired t-test
or one-way ANOVA combined with Bonferroni's Multiple
Comparison Test as a post-hoc test. Significance was
determined when p < 0.05.
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